US Stock MarketDetailed Quotes

FUSN Fusion Pharmaceuticals

Watchlist

21.460
-0.080-0.37%

Close May 16 16:00 ET

21.460
0.0000.00%

Post 16:00 ET

1.83BMarket Cap-15328P/E (TTM)

Fusion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-7.36%-27.31M

-11.64%-81.8M

7.33%-17.94M

12.88%-18.84M

-13.10%-19.58M

-69.90%-25.44M

3.25%-73.28M

-18.60%-19.36M

-0.53%-21.63M

-0.05%-17.32M

Net income from continuing operations

-38.61%-33.67M

-8.32%-94.9M

-14.47%-28.18M

28.16%-17.25M

-31.99%-25.18M

-22.01%-24.29M

-8.10%-87.61M

-42.82%-24.62M

-23.59%-24.01M

28.97%-19.07M

Depreciation and amortization

32.23%361K

47.96%1.35M

45.56%361K

54.55%374K

56.02%337K

34.48%273K

43.38%909K

34.78%248K

30.81%242K

40.26%216K

Deferred tax

18.02%-405K

126.72%845K

548.08%2.92M

54.01%-882K

-175.10%-696K

-45.29%-494K

-219.07%-3.16M

-102.80%-651K

-646.30%-1.92M

38.74%-253K

Other non cash items

42.94%759K

28.97%3.31M

198.37%1.28M

-63.39%562K

216.16%939K

72.96%531K

-74.33%2.57M

52.67%429K

523.98%1.54M

-96.78%297K

Change In working capital

166.99%2.35M

-135.98%-1.32M

-1.45%2.98M

-26,675.00%-4.25M

360.24%3.46M

-279.87%-3.5M

125.08%3.66M

259.80%3.03M

100.32%16K

35.22%-1.33M

-Change in receivables

125.00%7K

-81.76%54K

-77.92%34K

155.26%21K

-81.88%27K

-190.32%-28K

182.91%296K

370.18%154K

78.77%-38K

223.14%149K

-Change in prepaid assets

76.98%-613K

-118.73%-437K

59.11%3.36M

-26.81%-2.12M

218.18%988K

-197.51%-2.66M

150.41%2.33M

507.92%2.11M

55.17%-1.68M

-400.72%-836K

-Change in payables and accrued expense

739.10%4.1M

-130.80%-956K

-53.52%765K

-102.82%-50K

-880.00%-1.03M

-208.65%-642K

350.32%3.1M

584.12%1.65M

-54.75%1.77M

-114.25%-105K

-Change in other current assets

-468.36%-652K

5,092.38%5.45M

385.47%1.47M

-57.37%159K

2,483.69%3.64M

65.42%177K

101.60%105K

-45.35%-516K

107.91%373K

106.05%141K

-Change in other current liabilities

-44.22%-499K

-200.88%-3.43M

-805.46%-2.65M

10.10%-258K

39.08%-173K

-25.36%-346K

-38.01%-1.14M

-41.55%-293K

-42.79%-287K

-33.96%-284K

-Change in other working capital

----

-92.68%-2M

--0

----

-7.90%-1.04M

81.01%-79K

12.33%-128K

---393K

Cash from discontinued investing activities

Operating cash flow

-7.36%-27.31M

-11.64%-81.8M

7.33%-17.94M

12.88%-18.84M

-13.10%-19.58M

-69.90%-25.44M

3.25%-73.28M

-18.60%-19.36M

-0.53%-21.63M

-0.05%-17.32M

Investing cash flow

Cash flow from continuing investing activities

-186.90%-70.37M

-285.23%-42.76M

87.79%-5.24M

-64.22%13.33M

-372.99%-26.32M

-228.21%-24.53M

-38.88%23.09M

-238.96%-42.93M

15.62%37.25M

163.49%9.64M

Net PPE purchase and sale

-9.08%-1.33M

-81.61%-3.89M

-56.21%-1.48M

-113.06%-473K

-89.33%-710K

-105.55%-1.22M

-43.66%-2.14M

-76.58%-950K

-38.75%-222K

-79.43%-375K

Net investment purchase and sale

-196.23%-69.04M

-254.08%-38.87M

91.05%-3.76M

-63.17%13.8M

-355.68%-25.61M

-218.14%-23.31M

-35.75%25.23M

-233.56%-41.98M

15.73%37.47M

158.95%10.02M

Cash from discontinued investing activities

Investing cash flow

-186.90%-70.37M

-285.23%-42.76M

87.79%-5.24M

-64.22%13.33M

-372.99%-26.32M

-228.21%-24.53M

-38.88%23.09M

-238.96%-42.93M

15.62%37.25M

163.49%9.64M

Financing cash flow

Cash flow from continuing financing activities

7.55%64.01M

248.63%142.01M

44,064.12%57.86M

-98.87%328K

143.37%24.31M

3,382.45%59.52M

11,638.62%40.73M

362.00%131K

50,610.53%28.91M

4,656.19%9.99M

Net issuance payments of debt

--14.92M

--0

--34.69M

--0

--24.86M

----

Net common stock issuance

-23.52%48.47M

2,396.13%145.13M

43,283.33%57.27M

-98.87%45K

32,929.73%24.44M

3,795.02%63.37M

--5.81M

--132K

--3.98M

--74K

Proceeds from stock option exercised by employees

--627K

303.54%912K

59,000.00%589K

372.73%312K

-86.08%11K

--0

-63.67%226K

-111.11%-1K

-75.82%66K

-62.38%79K

Net other financing activities

----

---4.03M

--0

---29K

---145K

---3.86M

----

Cash from discontinued financing activities

Financing cash flow

7.55%64.01M

248.63%142.01M

44,064.12%57.86M

-98.87%328K

143.37%24.31M

3,382.45%59.52M

11,638.62%40.73M

362.00%131K

50,610.53%28.91M

4,656.19%9.99M

Net cash flow

Beginning cash position

38.47%62.77M

-17.26%45.33M

-73.86%28.11M

-47.13%33.29M

-9.52%54.89M

-17.26%45.33M

-40.71%54.79M

166.95%107.5M

113.42%62.97M

41.19%60.66M

Current changes in cash

-452.45%-33.67M

284.44%17.44M

155.77%34.67M

-111.64%-5.19M

-1,033.64%-21.6M

62.75%9.55M

74.86%-9.46M

-528.17%-62.17M

313.68%44.53M

117.21%2.31M

End cash Position

-46.97%29.11M

38.47%62.77M

-73.86%28.11M

-47.13%33.29M

-9.52%54.89M

-17.26%45.33M

166.95%107.5M

113.42%62.97M

Free cash flow

-7.43%-28.64M

-13.62%-85.69M

4.36%-19.43M

11.60%-19.31M

-14.71%-20.29M

-71.26%-26.66M

2.35%-75.42M

-20.45%-20.31M

-0.82%-21.85M

-1.00%-17.69M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-7.36%-27.31M	-11.64%-81.8M	7.33%-17.94M	12.88%-18.84M	-13.10%-19.58M	-69.90%-25.44M	3.25%-73.28M	-18.60%-19.36M	-0.53%-21.63M	-0.05%-17.32M
Net income from continuing operations	-38.61%-33.67M	-8.32%-94.9M	-14.47%-28.18M	28.16%-17.25M	-31.99%-25.18M	-22.01%-24.29M	-8.10%-87.61M	-42.82%-24.62M	-23.59%-24.01M	28.97%-19.07M
Depreciation and amortization	32.23%361K	47.96%1.35M	45.56%361K	54.55%374K	56.02%337K	34.48%273K	43.38%909K	34.78%248K	30.81%242K	40.26%216K
Deferred tax	18.02%-405K	126.72%845K	548.08%2.92M	54.01%-882K	-175.10%-696K	-45.29%-494K	-219.07%-3.16M	-102.80%-651K	-646.30%-1.92M	38.74%-253K
Other non cash items	42.94%759K	28.97%3.31M	198.37%1.28M	-63.39%562K	216.16%939K	72.96%531K	-74.33%2.57M	52.67%429K	523.98%1.54M	-96.78%297K
Change In working capital	166.99%2.35M	-135.98%-1.32M	-1.45%2.98M	-26,675.00%-4.25M	360.24%3.46M	-279.87%-3.5M	125.08%3.66M	259.80%3.03M	100.32%16K	35.22%-1.33M
-Change in receivables	125.00%7K	-81.76%54K	-77.92%34K	155.26%21K	-81.88%27K	-190.32%-28K	182.91%296K	370.18%154K	78.77%-38K	223.14%149K
-Change in prepaid assets	76.98%-613K	-118.73%-437K	59.11%3.36M	-26.81%-2.12M	218.18%988K	-197.51%-2.66M	150.41%2.33M	507.92%2.11M	55.17%-1.68M	-400.72%-836K
-Change in payables and accrued expense	739.10%4.1M	-130.80%-956K	-53.52%765K	-102.82%-50K	-880.00%-1.03M	-208.65%-642K	350.32%3.1M	584.12%1.65M	-54.75%1.77M	-114.25%-105K
-Change in other current assets	-468.36%-652K	5,092.38%5.45M	385.47%1.47M	-57.37%159K	2,483.69%3.64M	65.42%177K	101.60%105K	-45.35%-516K	107.91%373K	106.05%141K
-Change in other current liabilities	-44.22%-499K	-200.88%-3.43M	-805.46%-2.65M	10.10%-258K	39.08%-173K	-25.36%-346K	-38.01%-1.14M	-41.55%-293K	-42.79%-287K	-33.96%-284K
-Change in other working capital	----	-92.68%-2M	--0	----	----	----	-7.90%-1.04M	81.01%-79K	12.33%-128K	---393K
Cash from discontinued investing activities
Operating cash flow	-7.36%-27.31M	-11.64%-81.8M	7.33%-17.94M	12.88%-18.84M	-13.10%-19.58M	-69.90%-25.44M	3.25%-73.28M	-18.60%-19.36M	-0.53%-21.63M	-0.05%-17.32M
Investing cash flow
Cash flow from continuing investing activities	-186.90%-70.37M	-285.23%-42.76M	87.79%-5.24M	-64.22%13.33M	-372.99%-26.32M	-228.21%-24.53M	-38.88%23.09M	-238.96%-42.93M	15.62%37.25M	163.49%9.64M
Net PPE purchase and sale	-9.08%-1.33M	-81.61%-3.89M	-56.21%-1.48M	-113.06%-473K	-89.33%-710K	-105.55%-1.22M	-43.66%-2.14M	-76.58%-950K	-38.75%-222K	-79.43%-375K
Net investment purchase and sale	-196.23%-69.04M	-254.08%-38.87M	91.05%-3.76M	-63.17%13.8M	-355.68%-25.61M	-218.14%-23.31M	-35.75%25.23M	-233.56%-41.98M	15.73%37.47M	158.95%10.02M
Cash from discontinued investing activities
Investing cash flow	-186.90%-70.37M	-285.23%-42.76M	87.79%-5.24M	-64.22%13.33M	-372.99%-26.32M	-228.21%-24.53M	-38.88%23.09M	-238.96%-42.93M	15.62%37.25M	163.49%9.64M
Financing cash flow
Cash flow from continuing financing activities	7.55%64.01M	248.63%142.01M	44,064.12%57.86M	-98.87%328K	143.37%24.31M	3,382.45%59.52M	11,638.62%40.73M	362.00%131K	50,610.53%28.91M	4,656.19%9.99M
Net issuance payments of debt	--14.92M	--0	--0	--0	--0	--0	--34.69M	--0	--24.86M	----
Net common stock issuance	-23.52%48.47M	2,396.13%145.13M	43,283.33%57.27M	-98.87%45K	32,929.73%24.44M	3,795.02%63.37M	--5.81M	--132K	--3.98M	--74K
Proceeds from stock option exercised by employees	--627K	303.54%912K	59,000.00%589K	372.73%312K	-86.08%11K	--0	-63.67%226K	-111.11%-1K	-75.82%66K	-62.38%79K
Net other financing activities	----	---4.03M	--0	---29K	---145K	---3.86M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	7.55%64.01M	248.63%142.01M	44,064.12%57.86M	-98.87%328K	143.37%24.31M	3,382.45%59.52M	11,638.62%40.73M	362.00%131K	50,610.53%28.91M	4,656.19%9.99M
Net cash flow
Beginning cash position	38.47%62.77M	-17.26%45.33M	-73.86%28.11M	-47.13%33.29M	-9.52%54.89M	-17.26%45.33M	-40.71%54.79M	166.95%107.5M	113.42%62.97M	41.19%60.66M
Current changes in cash	-452.45%-33.67M	284.44%17.44M	155.77%34.67M	-111.64%-5.19M	-1,033.64%-21.6M	62.75%9.55M	74.86%-9.46M	-528.17%-62.17M	313.68%44.53M	117.21%2.31M
End cash Position	-46.97%29.11M	38.47%62.77M	38.47%62.77M	-73.86%28.11M	-47.13%33.29M	-9.52%54.89M	-17.26%45.33M	-17.26%45.33M	166.95%107.5M	113.42%62.97M
Free cash flow	-7.43%-28.64M	-13.62%-85.69M	4.36%-19.43M	11.60%-19.31M	-14.71%-20.29M	-71.26%-26.66M	2.35%-75.42M	-20.45%-20.31M	-0.82%-21.85M	-1.00%-17.69M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall